Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FPS | fiducian india fund | 03/03/15 | 15 | 8.6K | |||
|
|||||||
FPS | Ann: Removal from Official List | 24/02/15 | 0 | 704 | |||
|
|||||||
FPS +FID | Ann: Implementation of Scheme of Arrangement | 20/02/15 | 0 | 786 | |||
|
|||||||
FID +FPS | Ann: Implementation of Scheme of Arrangement | 20/02/15 | 0 | 758 | |||
|
|||||||
FPS +FID | Ann: Compliance by Fiducian with LR 3.1 | 09/02/15 | 0 | 764 | |||
|
|||||||
FPS | Ann: Suspension from Official Quotation | 09/02/15 | 0 | 1.0K | |||
|
|||||||
FPS | FPS - Fiducian Portfolio Services Limited | 06/02/15 | 8 | 4.0K | |||
|
|||||||
FPS | Ann: Lodgement of Court Orders relating to Fiducian Restructure | 06/02/15 | 0 | 578 | |||
|
See All Discussions